Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.97%15.16B | 1.92%56.33B | 0.30%12.53B | 4.48%55.27B | 5.58%14.13B | -6.98%13B | 14.91%15.64B | 4.75%12.5B | 20.61%52.9B | 17.00%13.38B |
| Cost of revenue | 17.94%10.92B | 0.68%38.39B | 7.09%9.26B | 7.18%38.13B | 8.95%10.06B | -3.81%8.83B | 14.70%10.61B | 9.08%8.65B | 20.52%35.58B | 16.33%9.23B |
| Gross profit | 29.56%4.24B | 4.69%17.94B | -14.91%3.28B | -1.09%17.14B | -1.93%4.07B | -13.02%4.18B | 15.34%5.04B | -3.82%3.85B | 20.79%17.33B | 18.55%4.15B |
| Operating expense | 2.89%3.17B | 12.79%12.63B | 7.01%3.08B | 7.86%11.2B | 19.31%2.93B | 2.94%2.7B | -0.48%2.69B | 10.68%2.88B | 5.72%10.38B | 3.59%2.46B |
| Operating profit | 460.21%1.07B | -10.61%5.31B | -80.25%191M | -14.46%5.94B | -32.61%1.15B | -32.23%1.48B | 41.00%2.35B | -30.83%967M | 53.53%6.94B | 49.82%1.7B |
| Net non-operating interest income (expenses) | -22.92%37M | 11.76%171M | 108.70%48M | 212.24%153M | 86.96%43M | 155.00%51M | 125.00%36M | 330.00%23M | 345.45%49M | 483.33%23M |
| Non-operating interest income | -16.85%74M | 20.07%329M | 71.15%89M | 144.64%274M | 122.86%78M | 136.36%78M | 127.59%66M | 246.67%52M | 138.30%112M | 218.18%35M |
| Non-operating interest expense | -9.76%37M | 30.58%158M | 41.38%41M | 92.06%121M | 191.67%35M | 107.69%27M | 130.77%30M | 16.00%29M | 75.00%63M | -29.41%12M |
| Net investment income | -103.49%-21M | -107.81%-77M | -9.90%601M | 62.17%986M | 1,037.21%489M | 29.25%-300M | -61.99%130M | 3.09%667M | 113.33%608M | -85.99%43M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 80.39%-10M | 93.94%-2M | -24.39%-51M | -143.75%-7M | -87.18%5M | 76.12%-16M | -13.79%-33M | -41M | 16M |
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 94.98%-11M | -614.38%-2.29B | -10,850.00%-219M | 48.80%-320M | -27.92%-252M | -95.65%-45M | 52.27%-21M | 99.45%-2M | -144.14%-625M | -55.12%-197M |
| Less:Restructuring and mergern&acquisition | ---- | --1.99B | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -190.11%-82M | -62.00%76M | 4,450.00%91M | -51.92%200M | 6,700.00%132M | 136.84%45M | -44.74%21M | -99.45%2M | 311.88%416M | -113.33%-2M |
| Less:Write off | -27.34%93M | 82.50%219M | --128M | -42.58%120M | -39.70%120M | --0 | ---- | ---- | 34.84%209M | 77.68%199M |
| Other non-operating income (expenses) | 216.67%95M | -32.12%112M | 3,100.00%30M | 57.14%165M | 666.67%138M | 420.00%26M | -92.31%2M | -101.79%-1M | 1,212.50%105M | 1,700.00%18M |
| Income before tax | 81.11%1.17B | -53.17%3.22B | -60.17%646M | -2.35%6.87B | -2.88%1.55B | -32.35%1.22B | 27.85%2.48B | -4.59%1.62B | 53.92%7.03B | 22.06%1.6B |
| Income tax | 184.52%680M | -28.77%807M | -29.08%239M | -16.75%1.13B | -44.99%203M | -76.32%72M | 16.29%521M | 40.42%337M | 120.23%1.36B | 14.24%369M |
| Net income | 20.15%489M | -57.99%2.41B | -68.30%407M | 1.11%5.74B | 9.67%1.35B | -23.34%1.14B | 31.39%1.96B | -12.05%1.28B | 43.52%5.67B | 24.62%1.23B |
| Net income continuous operations | 20.39%490M | -57.98%2.41B | -68.33%407M | 1.11%5.74B | 9.76%1.35B | -23.39%1.14B | 31.32%1.96B | -11.99%1.29B | 43.55%5.67B | 24.62%1.23B |
| Noncontrolling interests | -157.14%-20M | -277.46%-252M | 6.06%35M | 8.40%142M | 27.50%51M | -60.98%16M | 55.56%42M | 43.48%33M | 244.74%131M | 48.15%40M |
| Net income attributable to the company | 37.47%510M | -52.40%2.66B | -70.34%371M | 0.94%5.59B | 9.07%1.3B | -22.22%1.13B | 30.78%1.92B | -12.88%1.25B | 41.60%5.54B | 24.06%1.19B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 37.47%510M | -52.40%2.66B | -70.34%371M | 0.94%5.59B | 9.07%1.3B | -22.22%1.13B | 30.78%1.92B | -12.88%1.25B | 41.60%5.54B | 24.06%1.19B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 50.98%23.9 | -50.26%118.25 | -70.24%15.83 | 0.92%237.75 | 9.01%55.19 | -22.27%47.9 | 30.83%81.47 | -12.89%53.19 | 41.73%235.58 | 24.15%50.63 |
| Diluted earnings per share | 50.98%23.9 | -50.26%118.25 | -70.24%15.83 | 0.92%237.75 | 9.01%55.19 | -22.24%47.9 | 30.80%81.4494 | -12.89%53.19 | 41.73%235.58 | 24.15%50.6296 |
| Dividend per share | 0 | 11.11%100 | 0 | 12.50%90 | 12.50%90 | 0 | 0 | 0 | 33.33%80 | 33.33%80 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |